Who owns the MONODAC trademark?

The MONODAC trademark is owned by C4 Therapeutics, Inc..

What class is the MONODAC trademark registered in?

The MONODAC trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for MONODAC?

The USPTO serial number for MONODAC is 90049843.

What is the registration number for MONODAC?

MONODAC is registered under USPTO registration number 7475373.

Sealvo

Home Search: MONODACMONODAC #90049843

Back

Updated Sep 20, 2026·31 searches this week

View on USPTO TSDR Find similar marks

MON

USPTO Trademark Record

REGISTERED

MONODAC

SN 90049843·Reg 7475373·Filed Jul 13, 2020

Owner C4 Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

MONODAC (Serial No. 90049843), Registration No. 7475373, is a registered US trademark filed on Jul 13, 2020 by C4 Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 13, 2030

Conflict Analysis

Full conflict analysis for MONODAC (SN 90049843) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

MONODAC (Reg. #7475373) is a registered US trademark that has been protecting its owner, C4 Therapeutics, Inc., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 13, 2020

SERIAL

90049843

REG#

7475373

REGISTERED

Aug 13, 2024

Filing Information

StatusREGISTERED

Filing DateJul 13, 2020

Serial Number90049843

Registration No.7475373

Registration DateAug 13, 2024

Status DateAug 13, 2024

Published for OppositionJun 08, 2021

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1581605

480Jan 13, 2021

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 31, 2023

First use in commerce: Oct 31, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

49 events

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 21, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 21, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 21, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Nov 21, 2024

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 21, 2024

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

REGISTERED-PRINCIPAL REGISTER

Aug 13, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 13, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 10, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 10, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 21, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO LIE

Jun 21, 2024

ASSIGNED TO LIE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 21, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 12, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 13, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 13, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Dec 13, 2023

STATEMENT OF USE PROCESSING COMPLETE

SU - NON-FINAL ACTION - WRITTEN

Dec 13, 2023

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Dec 13, 2023

NON-FINAL ACTION E-MAILED

TEAS STATEMENT OF USE RECEIVED

Dec 05, 2023

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 05, 2023

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 29, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 GRANTED

Jun 27, 2023

SOU EXTENSION 4 GRANTED

SOU EXTENSION 4 FILED

Jun 27, 2023

SOU EXTENSION 4 FILED

SOU TEAS EXTENSION RECEIVED

Jun 27, 2023

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 01, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 FILED

Jan 30, 2023

SOU EXTENSION 3 FILED

SOU TEAS EXTENSION RECEIVED

Jan 30, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 GRANTED

Jan 30, 2023

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 03, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Aug 01, 2022

SOU EXTENSION 2 GRANTED

SOU EXTENSION 2 FILED

Aug 01, 2022

SOU EXTENSION 2 FILED

SOU TEAS EXTENSION RECEIVED

Aug 01, 2022

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 03, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 GRANTED

Feb 01, 2022

SOU EXTENSION 1 GRANTED

SOU EXTENSION 1 FILED

Feb 01, 2022

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Feb 01, 2022

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 03, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 08, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Jun 08, 2021

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 19, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 06, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 24, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 23, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 23, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION E-MAILED

Oct 24, 2020

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Oct 24, 2020

NON-FINAL ACTION WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 24, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 22, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 10, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by C4 Therapeutics, Inc.

Additional USPTO filings from the same owner.

C4T

C4 THERAPEUTICS

86824725

C4 Therapeutics, Inc.

REGISTERED

BID

BIDAC

90430623

C4 Therapeutics, Inc.

REGISTERED

MON

MONODAC

90430706

C4 Therapeutics, Inc.

REGISTERED

LOG

LogoMark

88414984

C4 Therapeutics, Inc.

REGISTERED

Other Marks by Douglas R. Wolf

Additional USPTO filings handled by the same attorney of record.

SIG

SIGNAL

99393044

REGISTERED

DEL

DELIGHTED PETS

99476229

REGISTERED

CUR

CUREWELL CAPITAL

99605951

REGISTERED

CON

CONSENSUS ADVISORS

78927356

REGISTERED

MONODAC

Run a conflict check

Other Marks by C4 Therapeutics, Inc.

Other Marks by Douglas R. Wolf

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company